Personalised Medicine: An Opportunity for Investment
14th January 2009
LONDON, January 14 /PRNewswire/ -- The pharmaceutical industry is currently facing some key challenges. The
increase in drug development costs, a decrease in the number of drugs being
approved, and scrutiny from regulatory authorities are forcing companies to
look at alternative revenue generators. Patients themselves are also
demanding more effective and safer drugs.
(Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO)
more
All rights reserved. Terms and Conditions | Contact us
